| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 26.88 mm | 26.88 mm | 26.88 mm | 26.88 mm | 26.88 mm | 26.88 mm |
| Cash burn (monthly) | 4.49 mm | 4.69 mm | 4.38 mm | 5.56 mm | 4.34 mm | 5.64 mm |
| Cash used (since last report) | 22.75 mm | 23.75 mm | 22.18 mm | 28.17 mm | 21.97 mm | 28.55 mm |
| Cash remaining | 4.13 mm | 3.13 mm | 4.70 mm | -1.29 mm | 4.91 mm | -1.67 mm |
| Runway (months of cash) | 0.9 | 0.7 | 1.1 | -0.2 | 1.1 | -0.3 |
| 13F holders | Current |
|---|---|
| Total holders | 40 |
| Opened positions | 3 |
| Closed positions | 19 |
| Increased positions | 8 |
| Reduced positions | 12 |
| 13F shares | Current |
|---|---|
| Total value | 3.35 bn |
| Total shares | 14.07 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| HealthCap VII | 3.40 mm | $4.55 mm |
| AbbVie Biotechnology | 2.75 mm | $0.00 |
| Longview Innovation | 2.71 mm | $5.97 mm |
| Vanguard | 1.45 mm | $1.42 bn |
| Trustees Of The University Of Pennsylvania | 1.25 mm | $1.23 mm |
| TPG GP A | 561.44 k | $551.11 mm |
| BCS Barclays | 549.30 k | $539.00 k |
| BlackRock | 408.56 k | $401.05 mm |
| Geode Capital Management | 259.18 k | $254.46 mm |
| Renaissance Technologies | 206.76 k | $202.95 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 28 Jan 25 | Steven Kelly | Stock Option Common Stock | Grant | Acquire A | No | No | 0.5 | 500,000 | 250.00 k | 500,000 |
| 28 Jan 25 | Michael Klichinsky | Stock Option Common Stock | Grant | Acquire A | No | No | 0.5 | 221,000 | 110.50 k | 221,000 |
| 31 Oct 24 | Sohanya Roshan Cheng | Stock Option Common Stock | Grant | Acquire A | No | No | 0.97 | 38,700 | 37.54 k | 38,700 |
